Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf

Completed

• Conditions: Non Small Cells Lung Cancer

• Registration Number: NCT01562665
• Lead Sponsor: AstraZeneca

Brief Summary

The overall aim of the study is:

To provide accurate and reliable information regarding NSCLC clinical management across MENA region in order to detect unmet medical needs of this disease in terms of:

* Patient and hospital characteristics.

* Diagnostic and treatment approaches: initial and subsequent.

* Follow-up patterns in clinical management.

* Outcomes: symptoms, death, functionality, quality of life.

* Use of resources and burden on patients and health care systems.

Detailed Description

Epidemiological study to describe NSCLC clinical management patterns in MENA

Study Timeline

• Study First Submitted: 2012-02-22
• Study First Submitted QC: 2012-03-22
• Study First Posted: 2012-03-26
• Study Start: 2012-06
• Primary Completion: 2015-02
• Study Completion: 2015-02
• Status Verified: 2016-05
• Last Update Submitted: 2016-05-23
• Last Update Posted: 2016-05-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

• Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women, attending the responsible department of treating this type of patients for the first time between November 1st, 2011 and August 30th, 2012 For PRO

• Sub-sample:

  • ability to read and write since they will be asked to participate in the PRO part of the study.

• Selection will not be based on the disease stage of each patient, in order to avoid a selection bias.

Exclusion Criteria

• According to the study design there will not be any exclusion criteria in order to provide a high validity and to obtain the most accurate real daily practice information.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Use of health resources by collecting data about hospital description and characteristics, Disease Diagnosis Procedures and Therapy information	April 2014(26 Months)

Secondary Outcome Measures

Name	Time	Method
Patient-Reported Outcomes (PRO) through self-administered questionnaires and the patients will be asked to complete them at each evaluation visit(25% of the whole sample)	April 2014(26 Months)

Trial Locations

Locations (1)

Research Site; 🇦🇪 Alain - AbuAhabi, United Arab Emirates